Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Niki Katsiki, Apostolos I. Hatzitolios & Dimitri P. Mikhailidis. (2011) Naltrexone sustained-release (SR) + bupropion SR combination therapy for the treatment of obesity: ‘A new kid on the block’?. Annals of Medicine 43:4, pages 249-258.
Read now
Read now
Claudiu T Supuran, Anna Di Fiore & Giuseppina De Simone. (2008) Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity. Expert Opinion on Emerging Drugs 13:2, pages 383-392.
Read now
Read now
Articles from other publishers (22)
Oluwole Steve Ijarotimi, Opeyemi Rachael Fagoroye & Timilehin David Oluwajuyitan. (2023) Jute seed bioactive compounds: amino acids, polyphenolics, antioxidants and hydrolyzing enzymes inhibitory property. Journal of Future Foods 3:2, pages 183-189.
Crossref
Crossref
Belma Turan & Deniz Billur. 2021. Cellular and Biochemical Mechanisms of Obesity. Cellular and Biochemical Mechanisms of Obesity
313
335
.
Wilhelm Schänzer & Mario Thevis. (2017) Human sports drug testing by mass spectrometry. Mass Spectrometry Reviews 36:1, pages 16-46.
Crossref
Crossref
Luana Calabrone, Marilena Larocca, Stefania Marzocco, Giuseppe Martelli & Rocco Rossano. (2015) Total Phenols and Flavonoids Content, Antioxidant Capacity and Lipase Inhibition of Root and Leaf Horseradish (<i>Armoracia rusticana</i>) Extracts. Food and Nutrition Sciences 06:01, pages 64-74.
Crossref
Crossref
Jeffrey J. Olney, Montserrat Navarro & Todd E. Thiele. (2014) Targeting central melanocortin receptors: a promising novel approach for treating alcohol abuse disorders. Frontiers in Neuroscience 8.
Crossref
Crossref
Angelo Schenone, Lucilla Nobbio, Margherita Monti Bragadin, Giulia Ursino & Marina Grandis. (2011) Inherited Neuropathies. Current Treatment Options in Neurology 13:2, pages 160-179.
Crossref
Crossref
Yuji Haga, Sayaka Mizutani, Akira Naya, Hiroyuki Kishino, Hisashi Iwaasa, Masahiko Ito, Junko Ito, Minoru Moriya, Nagaaki Sato, Norihiro Takenaga, Akane Ishihara, Shigeru Tokita, Akio Kanatani & Norikazu Ohtake. (2011) Discovery of novel phenylpyridone derivatives as potent and selective MCH1R antagonists. Bioorganic & Medicinal Chemistry 19:2, pages 883-893.
Crossref
Crossref
André M. Faria, Marcio C. Mancini, Maria Edna de Melo, Cintia Cercato & Alfredo Halpern. (2010) Progressos recentes e novas perspectivas em farmacoterapia da obesidade. Arquivos Brasileiros de Endocrinologia & Metabologia 54:6, pages 516-529.
Crossref
Crossref
Leila Maria Marchi-Alves, Maria Suely Nogueira, Isabel Amélia Costa Mendes & Simone de Godoy. (2010) Leptina, hipertensão arterial e obesidade: importância das ações de enfermagem. Acta Paulista de Enfermagem 23:2, pages 286-290.
Crossref
Crossref
Mª Luisa Isidro & Fernando Cordido. (2010) Approved and Off-Label Uses of Obesity Medications, and Potential New Pharmacologic Treatment Options. Pharmaceuticals 3:1, pages 125-145.
Crossref
Crossref
Alfredo Halpern, Renata B. Pepe, Ana Paola Monegaglia, Mônica Beyruti, Maria Edna de Melo & Marcio C. Mancini. (2010) Efficacy and Tolerability of the Association of Sibutramine and Orlistat for Six Months in Overweight and Obese Patients. Journal of Obesity 2010, pages 1-5.
Crossref
Crossref
Vincenzo Alterio, Simona Maria Monti, Emanuela Truppo, Carlo Pedone, Claudiu T. Supuran & Giuseppina De Simone. (2010) The first example of a significant active site conformational rearrangement in a carbonic anhydrase-inhibitor adduct: the carbonic anhydrase I–topiramate complex. Organic & Biomolecular Chemistry 8:15, pages 3528.
Crossref
Crossref
Nora L. Nock & Nathan A. Berger. 2010. Cancer and Energy Balance, Epidemiology and Overview. Cancer and Energy Balance, Epidemiology and Overview
129
179
.
Seungjoo Lee, Dong Hyun Kim, Sung-Hwa Yoon & Jong Hoon Ryu. (2009) Sub-chronic administration of rimonabant causes loss of antidepressive activity and decreases doublecortin immunoreactivity in the mouse hippocampus. Neuroscience Letters 467:2, pages 111-116.
Crossref
Crossref
Jochen Krüger, Torsten Minuth, Werner Schröder & Jörn Werwath. (2008) Manufacturing and PEGylation of a Dual-Acting Peptide for Diabetes. European Journal of Organic Chemistry 2008:35, pages 5936-5945.
Crossref
Crossref
C. Zoccali & F. Mallamaci. (2008) Obesity, diabetes, adiponectin and the kidney: a podocyte affair. Nephrology Dialysis Transplantation 23:12, pages 3767-3770.
Crossref
Crossref
Robert H. Eckel. (2008) Nonsurgical Management of Obesity in Adults. New England Journal of Medicine 358:18, pages 1941-1950.
Crossref
Crossref
Themistoklis Tzotzas, Kostas Papazisis, Petros Perros & Gerasimos E Krassas. (2008) Use of Somatostatin Analogues in Obesity. Drugs 68:14, pages 1963-1973.
Crossref
Crossref
R. P. Vincent & C. W. Le Roux. (2007) New agents in development for the management of obesity. International Journal of Clinical Practice 61:12, pages 2103-2112.
Crossref
Crossref
Rahul B. Birari & Kamlesh K. Bhutani. (2007) Pancreatic lipase inhibitors from natural sources: unexplored potential. Drug Discovery Today 12:19-20, pages 879-889.
Crossref
Crossref
Kamlesh Kumar Bhutani, Rahul Birari & Kausik Kapat. (2019) Potential Anti-obesity and Lipid Lowering Natural Products: A Review. Natural Product Communications 2:3, pages 1934578X0700200.
Crossref
Crossref
Robert H. Mak, Wai Cheung & Jonathan Purnell. (2020) Ghrelin in Chronic Kidney Disease: Too Much or Too Little?. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 27:1, pages 51-55.
Crossref
Crossref